Apogee Therapeutics (APGE) Tax Provisions (2024 - 2026)
Apogee Therapeutics (APGE) posted quarterly Tax Provisions of $79000.0 for Q1 2026, down 4.82% year-over-year from $83000.0 in Q1 2025, and up 100.15% quarter-over-quarter from -$53.9 million in Q4 2025.
Powered by 
Analysis
Apogee Therapeutics (APGE) Tax Provisions (2024 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has reported Tax Provisions for 3 consecutive years, with $79000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Tax Provisions fell 4.82% year-over-year to $79000.0; the TTM figure through Mar 2026 stood at -$53.7 million (down 11593.46% YoY), while the FY2025 annual figure was -$53.7 million, down 9802.03% from the prior year.
- Tax Provisions rose to $79000.0 in Q1 2026 per APGE's latest filing, from -$53.9 million in the prior quarter.
- Across five years, Tax Provisions topped out at $83000.0 in Q1 2025 and bottomed at -$53.9 million in Q4 2025.
- Historically, Tax Provisions has averaged -$9.0 million across 3 years, with a median of $66500.0 in 2025.
- Annual changes were most pronounced in 2025 — Tax Provisions plunged 9841.88% — and 2026, when it dropped 4.82%.
- Apogee Therapeutics' Tax Provisions stood at -$542000.0 in 2024, then slumped by 9841.88% to -$53.9 million in 2025, then surged by 100.15% to $79000.0 in 2026.
- Business Quant data shows APGE's Tax Provisions at $79000.0 in Q1 2026, -$53.9 million in Q4 2025, and $61000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Apogee Therapeutics | 10.18 Bn | 9.20 Bn | - | 78,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 78,000.00 |
| Mar 31, 2026 | 79,000.00 |
| Dec 31, 2025 | -53.89 Mn |
| Sep 30, 2025 | 61,000.00 |
| Jun 30, 2025 | 72,000.00 |
| Mar 31, 2025 | 83,000.00 |
| Dec 31, 2024 | -38.25 Mn |